Algert Global’s Olema Pharmaceuticals OLMA Stock Holding History

Algert Global’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$535K	Buy	+35,880	New	+$799K	0.01%	960
2024 Q2	–	Sell	-33,580	Closed	-$380K	–	1570
2024 Q1	$380K	Buy	+33,580	New	+$433K	0.01%	836
2023 Q4	–	Sell	-47,630	Closed	-$588K	–	1223
2023 Q3	$588K	Sell	47,630 -10,460	-18%	-$107K	0.03%	695
2023 Q2	$525K	Buy	58,090 +45,640	+367%	+$276K	0.02%	808
2023 Q1	$43K	Sell	12,450 -9,790	-44%	-$39.9K	﹤0.01%	1106
2022 Q4	$54K	Hold	22,240	–	–	﹤0.01%	1102
2022 Q3	$61K	Buy	+22,240	New	+$94.3K	﹤0.01%	1133

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Algert Global's OLMA Position: Q1 2026 in Review

Algert Global opened a new position in Olema Pharmaceuticals (OLMA) in Q1 2026: 35,880 shares worth $535K. The stake represents 0.01% of the portfolio and ranks #960 among its holdings. This is a return to the name: Algert Global previously reported a position in OLMA as recently as Q1 2024.

Algert Global first reported a position in OLMA in Q3 2022 and has held it in 7 quarters since. The position peaked at $588K in Q3 2023. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

Algert Global held 35,880 shares of Olema Pharmaceuticals worth $535K as of Q1 2026.
Olema Pharmaceuticals was a new Algert Global position in Q1 2026.
Olema Pharmaceuticals made up 0.01% of Algert Global's portfolio in Q1 2026, its #960 holding.
Algert Global first reported a position in Olema Pharmaceuticals in Q3 2022 and has held it in 7 quarters since.
Algert Global's Olema Pharmaceuticals position peaked at $588K in Q3 2023.
195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.